Prostate cancer is one of the most common types of cancer in men and its treatment was constricted to surgery for confined state and androgen ablation for advanced disease until new options have become available. The present book covers a broad range of novel aspects of prostate cancer diagnosis, treatment and patient care, as well as new research on relevant cell biology. In detail, this special volume focusses on supportive modalities for prostate cancer patients, appropriate selection of novel therapeutic regimens, including inhibitors of steroidal synthesis, cytotoxic agents, as well as intermittent androgen suppression and the roles of prostate cancer stem cells and inflammatory processes
Prostate cancer is the second most common cancer in men with approximately 256,000 deaths reported w...
Despite many recent advances in the therapy for metastatic castration-resistant prostate cancer (mCR...
Contains fulltext : 48248schalken.pdf (publisher's version ) (Closed access)As pro...
In this book entitled "Prostate Cancer - Diagnostic and Therapeutic Advances", we highlight many of ...
Androgen deprivation therapy has become the mainstay of the treatment of advanced prostate cancer, b...
The number of males diagnosed with prostate cancer (PCa) is increasing all over the world. Most pati...
Prostate cancer is one of the malignancies that affects men and significantly contributes to increas...
Prostate cancer is an enigmatic disease. Although prostatic-intraepithelial neoplasia appears as ear...
Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent ...
As new evidence for prostate cancer treatment has emerged in the last few years, longstanding contro...
Prostate cancer (PCa) is today the second most common cancer in the world, with almost 400,000 death...
Prostate cancer is the most common cancer amongst men in the USA and the second most common malignan...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
Recurrent prostate cancer (PCa) remains a major clinical challenge. Invasive and metastatic PCa lesi...
Prostate cancer is the second most common cancer in men with approximately 256,000 deaths reported w...
Despite many recent advances in the therapy for metastatic castration-resistant prostate cancer (mCR...
Contains fulltext : 48248schalken.pdf (publisher's version ) (Closed access)As pro...
In this book entitled "Prostate Cancer - Diagnostic and Therapeutic Advances", we highlight many of ...
Androgen deprivation therapy has become the mainstay of the treatment of advanced prostate cancer, b...
The number of males diagnosed with prostate cancer (PCa) is increasing all over the world. Most pati...
Prostate cancer is one of the malignancies that affects men and significantly contributes to increas...
Prostate cancer is an enigmatic disease. Although prostatic-intraepithelial neoplasia appears as ear...
Novel drugs, drug sequences and combinations have improved the outcome of prostate cancer in recent ...
As new evidence for prostate cancer treatment has emerged in the last few years, longstanding contro...
Prostate cancer (PCa) is today the second most common cancer in the world, with almost 400,000 death...
Prostate cancer is the most common cancer amongst men in the USA and the second most common malignan...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
This book presents up-to-date information on one of the hottest topics in prostate cancer, namely bo...
Recurrent prostate cancer (PCa) remains a major clinical challenge. Invasive and metastatic PCa lesi...
Prostate cancer is the second most common cancer in men with approximately 256,000 deaths reported w...
Despite many recent advances in the therapy for metastatic castration-resistant prostate cancer (mCR...
Contains fulltext : 48248schalken.pdf (publisher's version ) (Closed access)As pro...